InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Wallace Peggy, Director. Director active across 1 companies, notably Cognition Therapeutics INC. In total, 2 reports have been logged. Total volume traded: €62k. The latest transaction was disclosed on 13 October 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€31,0363,000 shares@ €10.34520.026% mcap100.0% of flow
Common Stock
SEC:0001882178-21-000036·
Ideal exit: 10 Jul 2022 (T+270)
€31,0363,000 shares@ €10.34520.026% mcap50.0% of flow
Common Stock
SEC:0001882178-21-000036:0·
Ideal exit: 10 Jul 2022 (T+270)
2 of 2 declarations
About Wallace Peggy
Peggy Wallace is a Director at Cognition Therapeutics Inc. She participates in the strategic decisions and governance of the company, bringing her experience in the biotechnology sector. Her role is important in supporting the innovation and growth of the company.
